Rescue of α-synuclein cytotoxicity by insulin-like growth factors

Biochemical and Biophysical Research Communications

Volumn 385, Issue 3, 2009, Pages 434-438

  Kao, Shyan Yuan ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Synuclein; Insulin like growth factor 1; Parkinson disease; Protein aggregation

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-SYNUCLEIN; APOPTOSIS; CELLS, CULTURED; DOPAMINE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MUTATION; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 67349208526     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.089     Document Type: Article

References (30)

1. Gibb W.R., and Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 51 (1998) 745-752
2. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., and Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299 (2003) 256-259
3. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
4. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., González-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., and Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
5. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M., López de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., and Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
6. Papadimitriou A., Veletza V., Hadjigeorgiou G., Patrikiou A., Hirano M., and Anastasopoulos I. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance?. Neurology 52 (1999) 651-654
7. Polymeropoulos M., Higgins J., Golbe L., Johnson W., Ide S., Di Iorio G., Sanges G., Stenroos E., Pho L., Schaffer A., Lazzarini A., Nussbaum R., and Duvoisin R. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274 (1996) 1197-1199
8. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., and Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607
9. Maroyeaux L., and Scheller R.H. The rat brain synucleins: family of proteins transiently associated with neuronal membrane. Mol. Brain Res. 11 (1991) 335-343
10. Hashimoto M., Hsu L.J., Xia Y., Takeda A., Sisk A., Sundsmo M., Masliah E., Kitada T., Asakawa S., Hattori N., Matsumine H., Tamamura Y., and Minoshima S. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 10 (1999) 717-721
11. Paik S.R., Lee J.H., Kim D.H., Chang C.S., and Kim Y.S. Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35). FEBS Lett. 421 (1998) 73-76
12. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., and Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152 (1998) 879-884
13. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. Α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA 95 (1998) 6469-6473
14. Ueda K., Fukushima H., Masliah E., Xia X., Iwai A., Yoshimota M., Otero D.A.C., Kondo J., Ihara Y., and Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90 (1993) 11282-11286
15. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
16. Zarranz J.J., Alegre J., Gómez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., Llorens V., Gomez Tortosa E., del Ser T., Muñoz D.G., and de Yebenes J.G. The new mutation, E46K Of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55 (2004) 64-173
17. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
18. Dev K.K., van der Putten H., Sommer B., and Rovelli G. Part I: parkin-associated proteins and Parkinson's disease. Neuropharmacology 45 (2002) 1-13
19. Xu J., Kao S.-Y., Lee F.J.S., Song W., Jin L.-W., and Yankner B.A. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8 (2002) 600-606
20. Cookson M.R., and van der Brug M. Cell systems and the toxic mechanism(s) of α-synuclein. Exp. Neurol. 209 (2008) 5-11
21. Kramer M.L., and Schulz-Schaeffer W.J. Presynaptic α-synuclein aggregates not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 27 (2007) 1405-1410
22. Busiguina S., Fernandez A.M., Barrios V., Clark R., Tolbert D.L., Berciano J., and Torres-Aleman I. Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol. Dis. 7 (2000) 657-665
23. Quesada A., Lee B.Y., and Micevych P.E. PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev. Neurobiol. 68 (2008) 632-644
24. Trejo J.L., Carro E., Garcia-Galloway E., and Torres-Aleman I. Role of insulin-like growth factor I signaling in neurodegenerative diseases. J. Mol. Med. 82 (2004) 156-162
25. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., and Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 8 (2002) 1390-1397
26. Gatchel J.R., Watase K., Thaller C., Carson J.P., Jafar-Nejad P., Shaw C., Zu T., Orr H.T., and Zoghbi H.Y. The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7. Proc. Natl. Acad. Sci. USA 105 (2008) 1291-1296
27. Chen H.K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandez M.H., Aitken A., Skoulakis E.M., Orr H.T., Botas J., and Zoghbi H.Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113 (2003) 457-468
28. Humbert S., Bryson E.A., Cordelières F.P., Connors N.C., Datta S.R., Finkbeiner S., Greenberg M.E., and Saudou F. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell 2 (2002) 831-837
29. Offen D., Shtaif B., Hadad D., Weizman A., Melamed E., and Gil-Ad I. Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease. Neurosci. Lett. 316 (2001) 129-132
30. Ebert A.D., Beres A.J., Barber A.E., and Svendsen C.N. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp. Neurol. 209 (2008) 213-223